Chronic treatment with a synthetic cannabinoid CP-55,940 alters G-protein expression in the rat central nervous system

Molecular Brain Research

Volumn 44, Issue 2, 1997, Pages 191-197

  Rubino, T ^a   Patrini, G ^a   Parenti, M ^b   Massi, P ^a   Parolaro, D ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Cannabinoid tolerance; G protein expression; G protein level; Rat central nervous system

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABINOID; CANNABINOID RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA; NERVE PROTEIN; PROTEIN SUBUNIT;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; DRUG RESISTANCE; FOREBRAIN; GENE EXPRESSION; IN SITU HYBRIDIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; LEG; LIMB DEFORMITY; LOCOMOTION; LONG TERM CARE; MALE; MESENCEPHALON; NONHUMAN; OLFACTORY CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; THALAMUS;

ANALGESICS; ANIMALS; BRAIN; BRAIN MAPPING; CANNABINOIDS; CYCLOHEXANOLS; GTP-BINDING PROTEINS; IN SITU HYBRIDIZATION; MALE; NERVE TISSUE PROTEINS; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

ANIMALIA;

EID: 0031055103     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)00941-9     Document Type: Article

References (20)

1. Compton, D.R., Rice, K.C., De Costa, B.R., Razdan, R.K., Melvin, L.S., Jhonson, M.R. and Martin, B.R., Cannabinoid structure-relationships: correlation of receptor binding and in vivo activities, J. Pharmacol. Exp. Ther., 265 (1993) 218-226.
2. D'Amour, F.E. and. Smith, D.L., A method for determining loss of pain sensation, J. Pharmacol. Exp. Ther., 72 (1941) 74-86.
3. Devane, W.A., Dysarz, F.A., Johnson, M.R., Melvin, L.S. and Howlett, A.C., Determination and characterization of a cannabinoid receptor in rat brain, Mol. Pharmacol.. 34 (1988) 605-613.
4. 9-Tetrahydrocannabinol, CP-55,940 and Win 55,212, J. Pharmacol. Exp. Ther., 271 (1994) 1383-1390.
5. Felder, C.C., Veluz, J.S., Williams, H.L., Briley, E.M., and Matsuda, L., Cannabinoid agonists stimulate both receptor and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones, Mol. Pharmacol., 42 (1992) 838-845.
6. Herkenham, M., Lynn, A.B., Little, M.D., Johnson, M.R., Melvin, L.S., DeCosta, B.R. and Rice, K.C., Cannabinoid receptor localization in the brain, Proc. Natl. Acad. Sci. USA, 87 (1990) 1932-1936.
7. Howlett, A.C., Bidaut Russell, M., Devane, W.A., Melvine, L.S., Johnson, M.R. and Herkenham, M., The cannabinoid receptor: biochemical, anatomical and behavioral characterization, Trends Neurosci., 13 (1990) 420-423.
8. Jones, D.T. and Reed, R.R., Molecular cloning of five GTP-binding protein cDNA species from rat olfactory neuroepithelium, J. Biol. Chem., 262 (1987) 14241-14249.
9. Mackie, K. and Hill, B., Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells, Proc. Natl. Acad. Sci. USA, 89 (1992) 3825-3829.
10. Matsuda, L.A., Lolait, S.J., Brownstein, M.J., Young, A.C. and Bonner, T.I., Structure of a cannabinoid receptor and functional expression of the cloned cDNA, Nature, 346 (1990) 561-564.
11. Nestler, E.J., Erdos, J.J., Terwilliger, R., Duman, R.S. and Tallman, J.F., Regulation of G proteins by chronic morphine in the rat locus coeruleus, Brain Res., 476 (1989) 230-239.
12. Oviedo, A., Glowa, J. and Herkenham, M., Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study, Brain Res., 619 (1993) 293-302.
13. o mRNA in discrete brain regions of morphine-tolerant rats, Eur. J. Pharmacol. Mol. Pharmacol. Sect., 244 (1993) 211-222.
14. Paxinos, G., and Watson, C., The rat brain in stereotaxic coordinates, Academic press, New York, 1986.
15. Pertwee, R., The evidence for the existence of cannabinoid receptors, Gen. Pharmacol., 24 (1993) 811-824.
16. 9 tetrahydrocannabinol treatment, Pharmacol. Biochem. Behav., 47 (1994) 33-40.
17. Rubino, T., Massi, P., Patrini, G., Venier, I., Giagnoni, G. and Parolaro, D., Chronic CP-55,940 alters cannabinoid receptor mRNA in the rat brain: an in situ hybridization study, Neuroreport, 5 (1994) 2493-2496.
18. Rubino, T., Massi, P., Patrini, G., Venier, I., Giagnoni, G. and Parolaro, D., Effect of chronic exposure to naltrexone and opioid selective agonists on G protein mRNA levels in the rat nervous system, Mol. Brain Res., 23 (1994) 333-337.
19. Rubino, T., Parenti, M., Patrini, G., Massi, P. and Parolaro, D., Morphine withdrawal syndrome and G protein expression: a study of the time course in the rat central nervous system, Eur. J. Neurosci., 7 (1995) 2334-2340.
20. Terwilliger, R.Z., Beitner-Johnson, D., Sevarino, K.A., Crain, S.M. and Nestler, E.J., A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function, Brain Res., 548 (1991) 100-110.